Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Multiple Sclerosis Cannabis-based medicine (CBM) found more effective than placebo for MS spasticity
Cannabis-based medicine (CBM) found more effective than placebo for reducing MS spasticity

Christine Collin, MD, Senior Consultant in Neuro-rehabilitation at the Royal Berkshire and Battle Hospitals, et al., wrote the following in their article "Randomized Controlled Trial of Cannabis-Based Medicine in Spasticity Caused by Multiple Sclerosis," published in the Mar. 2007 European Journal of Neurology:

Quote:"Symptoms relating to spasticity are common in multiple sclerosis (MS) and can be difficult to treat. We have investigated the efficacy, safety and tolerability of a standardized ... cannabis-based medicine (CBM) containing delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD), upon spasticity in MS. A total of 189 subjects with definite MS and spasticity were randomized to receive daily doses of active preparation (n = 124) or placebo (n = 65) in a double blind study over 6 weeks...

The primary efficacy analysis... showed the active preparation to be significantly superior...
We conclude that this CBM [cannabis-based medicine] may represent a useful new agent for treatment of the symptomatic relief of spasticity in MS."
Mar. 2007 -Christine Collin, MD

Forum Jump:

Users browsing this thread: 1 Guest(s)